Literature DB >> 23588418

Another fork in the road--life or death decisions by the tumour suppressor p53.

Luis A Carvajal1, James J Manfredi.   

Abstract

In response to cellular stress signals, the tumour suppressor p53 accumulates and triggers a host of antineoplastic responses. For instance, DNA damage activates two main p53-dependent responses: cell cycle arrest and attendant DNA repair or apoptosis (cell death). It is broadly accepted that, in response to DNA damage, the function of p53 as a sequence-specific transcription factor is crucial for tumour suppression. The molecular determinants, however, that favour the initiation of either a p53-dependent cell cycle arrest (life) or apoptotic (death) transcriptional programme remain elusive. Gaining a clear understanding of the mechanisms controlling cell fate determination by p53 could lead to the identification of molecular targets for therapy, which could selectively sensitize cancer cells to apoptosis. This review summarizes the literature addressing this important question in the field. Special emphasis is given to the role of the p53 response element, post-translational modifications and protein-protein interactions on cell fate decisions made by p53 in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588418      PMCID: PMC3642373          DOI: 10.1038/embor.2013.25

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  69 in total

1.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

Review 2.  The RNA polymerase II core promoter: a key component in the regulation of gene expression.

Authors:  Jennifer E F Butler; James T Kadonaga
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

3.  The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.

Authors:  Paola Zacchi; Monica Gostissa; Takafumi Uchida; Clio Salvagno; Fabio Avolio; Stefano Volinia; Ze'ev Ronai; Giovanni Blandino; Claudio Schneider; Giannino Del Sal
Journal:  Nature       Date:  2002-10-02       Impact factor: 49.962

4.  The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.

Authors:  Hongwu Zheng; Han You; Xiao Zhen Zhou; Stephen A Murray; Takafumi Uchida; Gerburg Wulf; Ling Gu; Xiaoren Tang; Kun Ping Lu; Zhi-Xiong Jim Xiao
Journal:  Nature       Date:  2002-10-02       Impact factor: 49.962

5.  Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.

Authors:  Asra Mirza; Qun Wu; Luquan Wang; Terri McClanahan; W Robert Bishop; Ferdous Gheyas; Wei Ding; Beth Hutchins; Tish Hockenberry; Paul Kirschmeier; Jonathan R Greene; Suxing Liu
Journal:  Oncogene       Date:  2003-06-05       Impact factor: 9.867

6.  p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage.

Authors:  Joaquín M Espinosa; Ramiro E Verdun; Beverly M Emerson
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

7.  Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.

Authors:  Jerry E Chipuk; Tomomi Kuwana; Lisa Bouchier-Hayes; Nathalie M Droin; Donald D Newmeyer; Martin Schuler; Douglas R Green
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  ASPP1 and ASPP2: common activators of p53 family members.

Authors:  Daniele Bergamaschi; Yardena Samuels; Boquan Jin; Sai Duraisingham; Tim Crook; Xin Lu
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.

Authors:  Alberto Inga; Francesca Storici; Thomas A Darden; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

View more
  83 in total

1.  p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation.

Authors:  Natalia Artigas; Beatriz Gámez; Mónica Cubillos-Rojas; Cristina Sánchez-de Diego; José Antonio Valer; Gabriel Pons; José Luis Rosa; Francesc Ventura
Journal:  Cell Death Differ       Date:  2017-08-04       Impact factor: 15.828

2.  Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.

Authors:  Elizabeth A White; Johanna Walther; Hassan Javanbakht; Peter M Howley
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

3.  Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.

Authors:  Jia-Xuan Qiu; Zhi-Wei Zhou; Zhi-Xu He; Ruan Jin Zhao; Xueji Zhang; Lun Yang; Shu-Feng Zhou; Zong-Fu Mao
Journal:  Drug Des Devel Ther       Date:  2015-01-07       Impact factor: 4.162

Review 4.  Cycling through developmental decisions: how cell cycle dynamics control pluripotency, differentiation and reprogramming.

Authors:  Abdenour Soufi; Stephen Dalton
Journal:  Development       Date:  2016-12-01       Impact factor: 6.868

5.  The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.

Authors:  Jeanine L Van Nostrand; Alice Brisac; Stephano S Mello; Suzanne B R Jacobs; Richard Luong; Laura D Attardi
Journal:  Cancer Discov       Date:  2015-03-26       Impact factor: 39.397

6.  Two Faces of SIVA.

Authors:  Lois Resnick-Silverman; James J Manfredi
Journal:  Cancer Discov       Date:  2015-06       Impact factor: 39.397

7.  DNA Damage Response Regulates Initiation of Liver Regeneration Following Acetaminophen Overdose.

Authors:  Prachi Borude; Bharat Bhushan; Udayan Apte
Journal:  Gene Expr       Date:  2018-03-14

8.  Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.

Authors:  Lei Duan; Ricardo E Perez; Michael Hansen; Steven Gitelis; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

9.  Alpha ketoglutarate levels, regulated by p53 and OGDH, determine autophagy and cell fate/apoptosis in response to Nutlin-3a.

Authors:  Lei Duan; Ricardo E Perez; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2018-10-05       Impact factor: 4.742

10.  A Chinese Decoction, Kuan-Sin-Yin, Improves Autonomic Function and Cancer-Related Symptoms of Metastatic Colon Cancer.

Authors:  Tsai-Ju Chien; Chia-Yu Liu; Pin-Hao Ko; Chung-Hua Hsu
Journal:  Integr Cancer Ther       Date:  2015-11-25       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.